-
ONE NATIONAL PROTOCOL, MANY LOCAL REALITIES: A REAL-WORLD ANALYSIS OF THE ADRENAL INSUFFICIENCY CLINICAL GUIDELINE IN BRAZIL'S UNIFIED HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
CLINICAL SIGNIFICANCE OF AVAILABLE DRUG INFORMATION RESOURCES REGARDING DRUG-DRUG INTERACTIONS: AN AUDIT FROM A TERTIARY CARE CANCER CENTRE IN INDIA
Aug 11, 2026, 17:16 PM -
MULTI-CRITERIA DECISION ANALYSIS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF MCDA FRAMEWORKS SUPPORTING DRUG REIMBURSEMENT DECISIONS
Aug 11, 2026, 17:16 PM -
A COMPARISON OF HEALTHCARE PRACTITIONER PREFERENCE FOR INFOGRAPHICS DEVELOPED USING TRADITIONAL METHODS VERSUS GENERATIVE ARTIFICIAL INTELLIGENCE
Aug 11, 2026, 17:16 PM -
ECONOMIC AND HUMANISTIC BURDEN OF IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF NEUROENDOCRINE TUMORS IN GERMANY: INSIGHTS FROM A NATIONAL CANCER REGISTRY
Aug 11, 2026, 17:16 PM -
CONCENTRATION OF PHARMACEUTICAL COSTS AND REIMBURSEMENTS IN FINLAND, 2020-2025
Aug 11, 2026, 17:16 PM -
PATIENT-CENTRED EVIDENCE GENERATION USING CLINICAL OUTCOME ASSESSMENTS, PATIENT PREFERENCE INFORMATION AND DIGITAL HEALTH TECHNOLOGY MEASURES: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
ASSESSING ORPHAN MEDICINES UNDER THE EUROPEAN UNION (EU) HEALTH TECHNOLOGY ASSESSMENT REGULATION (HTAR): IS CURRENT HTA GUIDANCE FIT FOR PURPOSE?
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF SPHERE-9 CATHETER IN PATIENTS WITH ATRIAL TACHYARRHYTHMIA IN TURKIYE
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF EMPLOYER-FUNDED LIPOPROTEIN(A) TESTING IN BULGARIA
Aug 11, 2026, 17:16 PM -
INCREASING HEALTHCARE RESOURCE UTILIZATION WITH RECURRENT ASCVD EVENTS AND SUBOPTIMAL LDL-C MANAGEMENT
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF AN INDIVIDUAL PATIENT-LEVEL SIMULATION OBESITY MODEL TO ESTIMATE OBESITY PROGRESSION
Aug 11, 2026, 17:16 PM -
REAL-WORLD TIME AND COSTS ASSOCIATED WITH PREPARATION AND ADMINISTRATION OF SUBCUTANEOUS (SC) VS. INTRAVENOUS (IV) NIVOLUMAB FOR CANCER TREATMENT
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF MEDICINES IN CATALONIA (SPAIN) IN 2025: ECONOMIC EVIDENCE AND GAPS
Aug 11, 2026, 17:16 PM -
THE FRENCH DIRECT ACCESS PATHWAY: WHAT HAVE WE LEARNED AFTER THREE YEARS?
Aug 11, 2026, 17:16 PM -
DISTRIBUTION OF PHARMACEUTICALS REIMBURSED AT A 50% RATE BY ANATOMICAL THERAPEUTIC CHEMICAL (ATC) GROUP IN ESTONIA, 2023-2026: AN ANALYSIS USING ESTONIAN HEALTH INSURANCE FUND (EHIF) DATA
Aug 11, 2026, 17:16 PM -
THE IMPACT OF STUDENTS' VOICES ON THEME EQUITY AND INCLUSION TO PROMOTE EDUCATIONAL OUTCOMES IN HIGHER EDUCATION: A LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
GENERIC HRQOL ADVANTAGE AMONG BIOLOGIC TREATED PATIENTS WITH SEVERE ASTHMA IN GREECE: EVIDENCE FROM ROUTINE SPECIALIST CARE
Aug 11, 2026, 17:16 PM -
EXPLORING PERSPECTIVES ON ADULT PNEUMOCOCCAL VACCINATION: A QUALITATIVE PREFERENCE STUDY OF HEALTH CARE PROVIDERS (HCPS) AND HEALTH CARE CONSUMERS (HCCS) IN FRANCE, SPAIN, AND SOUTH KOREA
Aug 11, 2026, 17:16 PM
